These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19750066)

  • 21. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
    Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
    Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A peer support programme for enhancing adherence to oral antipsychotic medication in consumers with schizophrenia.
    Boardman G; McCann T; Kerr D
    J Adv Nurs; 2014 Oct; 70(10):2293-302. PubMed ID: 24628395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia--a review of the past decade.
    Barkhof E; Meijer CJ; de Sonneville LM; Linszen DH; de Haan L
    Eur Psychiatry; 2012 Jan; 27(1):9-18. PubMed ID: 21561742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tackling medication non-adherence in severe mental illness: where are we going wrong?
    Brown E; Gray R
    J Psychiatr Ment Health Nurs; 2015 Apr; 22(3):192-8. PubMed ID: 25655400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of non-adherent behaviour in early psychosis.
    Hui CL; Chen EY; Kan CS; Yip KC; Law CW; Chiu CP
    Aust N Z J Psychiatry; 2006 May; 40(5):446-51. PubMed ID: 16683971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of partial compliance.
    Marder SR
    J Clin Psychiatry; 2003; 64 Suppl 16():3-9. PubMed ID: 14680412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interventions to improve antipsychotic medication adherence: review of recent literature.
    Dolder CR; Lacro JP; Leckband S; Jeste DV
    J Clin Psychopharmacol; 2003 Aug; 23(4):389-99. PubMed ID: 12920416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuity of antipsychotic medication management for Medicaid patients with schizophrenia.
    Farley JF; Wang CC; Hansen RA; Voils CI; Maciejewski ML
    Psychiatr Serv; 2011 Jul; 62(7):747-52. PubMed ID: 21724787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia.
    Eticha T; Teklu A; Ali D; Solomon G; Alemayehu A
    PLoS One; 2015; 10(3):e0120560. PubMed ID: 25816353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving adherence to antipsychotic pharmacotherapy.
    Masand PS; Narasimhan M
    Curr Clin Pharmacol; 2006 Jan; 1(1):47-56. PubMed ID: 18666377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient outcomes within schizophrenia treatment: a look at the role of long-acting injectable antipsychotics.
    Bera RB
    J Clin Psychiatry; 2014; 75 Suppl 2():30-3. PubMed ID: 24919169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.
    Ascher-Svanum H; Zhu B; Faries D; Lacro JP; Dolder CR
    J Clin Psychiatry; 2006 Jul; 67(7):1114-23. PubMed ID: 16889456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.
    Kim J; Ozzoude M; Nakajima S; Shah P; Caravaggio F; Iwata Y; De Luca V; Graff-Guerrero A; Gerretsen P
    Neuropharmacology; 2020 May; 168():107634. PubMed ID: 31077729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.
    Perkins DO; Johnson JL; Hamer RM; Zipursky RB; Keefe RS; Centorrhino F; Green AI; Glick IB; Kahn RS; Sharma T; Tohen M; McEvoy JP; Weiden PJ; Lieberman JA;
    Schizophr Res; 2006 Mar; 83(1):53-63. PubMed ID: 16529910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial compliance with antipsychotics and its impact on patient outcomes.
    Narasimhan M; Un Pae C; Masand N; Masand P
    Int J Psychiatry Clin Pract; 2007; 11(2):102-11. PubMed ID: 24937555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.
    Olivares JM; Rodriguez-Martinez A; Burón JA; Alonso-Escolano D; Rodriguez-Morales A;
    Appl Health Econ Health Policy; 2008; 6(1):41-53. PubMed ID: 18774869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.
    Offord S; Lin J; Mirski D; Wong B
    Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis.
    El Abdellati K; De Picker L; Morrens M
    Front Neurosci; 2020; 14():531763. PubMed ID: 33162877
    [No Abstract]   [Full Text] [Related]  

  • 39. Survey of medication adherence in patients with schizophrenia--Korean ADHES data.
    Kim SW; Yoon JS; Choi SK
    Hum Psychopharmacol; 2006 Dec; 21(8):533-7. PubMed ID: 17133616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies for improving adherence to second-generation antipsychotics in patients with schizophrenia by increasing ease of use.
    Burton SC
    J Psychiatr Pract; 2005 Nov; 11(6):369-78. PubMed ID: 16304505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.